Goldfinch Bio | 3,890 followers on LinkedIn. We aspire to save kidneys and end dialysis by delivering disease-modifying precision medicines for patients. | With our sole focus on kidney diseases, we aspire to be the world’s leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of disease. Our solution to address this growing need is applying precision medicine to pioneer the discovery, development and commercialization of kidney disease treatments.